To Heal Diabetic Foot Ulcers, A New Drug Harnesses Stem Cells Inside Us All : RushPRNews - Newswire & Global Press Release Distribution

Bookmark and Share

To Heal Diabetic Foot Ulcers, A New Drug Harnesses Stem Cells Inside Us All

November 12, 2009

Princeton, NJ (RPRN) 11/12/09 — Diabetic foot ulcers are the primary cause of hospital admissions for diabetics. Foot ulcers that heal improperly are at risk for infection, which can lead to amputation.  According to the American Diabetes Association, one in four patients with diabetic foot ulcers will eventually require lower-limb amputation.  Now science has found a way of mobilizing stem cells within the body to treat this health issue, which affects more than three million Americans annually.

Mesenchymal stem cells (MSCs), as distinct from the embryonic type, may be the key to healing diabetic foot ulcers.  These stem cells can differentiate into various cell types.  As a fetus develops, MSCs help drive its rapid initial growth; by the time we reach our teens, however, MSCs are mostly found in bone marrow.  

When wounded or burned, our skin craves MSCs, which it harbored when first growing.  In fact, recent studies show that surgically moving these cells from bone marrow onto hard-to-heal wounds accelerates healing.  

In contrast to surgically removing MSCs from bone marrow—a painful, time consuming and expensive process—a new topical drug, the novel angiotensin analog DSC127, appears to activate the mesenchymal stem cells in a patient’s body. 

“It appears that DSC127 directs MSCs to the injury site, mobilizing them to help repair wounded or burned skin, accelerate healing and reduce scar formation,” said Edward J. Quilty, Chairman & CEO of Derma Sciences Inc.  Based in Princeton, New Jersey, Derma Sciences develops, manufactures, and markets innovative wound care products.  “DSC127,” Quilty observed, “thus works as a catalyst for a stem cell treatment that is free of both the ethical controversies surrounding the medical use of fertilized embryos as well as potentially painful surgical interventions.”

Currently in a 75-patient Phase II diabetic foot ulcer clinical trial being conducted at some of the nation’s top institutions, the drug is being considered for additional indications including venous leg ulcers, arterial ulcers, pressure ulcers, thermal and chemical wounds, and scar prevention.  Pre-clinical animal studies have demonstrated the efficacy of the compound in accelerating healing and reducing scar formation. 

If DSC127 is approved for market, patients with diabetic foot ulcers may find a solution already exists within their own bodies.  For more information, visit

Media Contact Name: Janet Vasquez
Media Phone: 212-825-3210
Media Web Address:
Company Web Address:
About the author:

Janet Vasquez, Director of Corporate Communications

About IRG

We are The Investor Relations Group (IRG), a full-service corporate communications firm that provides investor relations and public relations services to nano-, micro- and small-cap companies providing them with the equivalent in-house services of a large-cap company.

Click here to see all news from this author/company

Filed Under: Article-byline, BREAKING NEWS, FDA- Pharmaceutical news

RUSH PR NEWS newswire and press release services at / Anne Howard

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.


Time to increase your public relations impact - PR coupon

SAN FRANCISCO 10/09/15 ·                 Your « AUTUMN» Coupon is here! And with it comes...

Saginaw Plaza Facility Celebrated Completion of ESPC with an Open House

FRAMINGHAM, Mass. & LANSING, Mich. 10/06/15 · Michigan Agency for Energy, long-term Saginaw Plaza facility...

Experience simple, fun karaoke at Vator Splash 2015

LOS ANGELES 10/05/15 · Come October 15, join us at Vator Splash...

Enjoy Karaoke in the comfort of your home with Moment

Los Angeles, CA 10/04/15 · We all have a singing moment. After hours...

Co-Founder of OXYwater Sentenced for Wire Fraud and Money Laundering

Washington, DC 10/01/15 · A co-founder of Imperial Integrative Health Research and...

Creative Bioarray Improves Tumor Cells Quality for Life Science Researchers

New York, NY 10/01/15 · - Creative Bioarray ( ), an innovative biotechnology company who...

Wake up your event audience with Livecube’s latest engagement technology

NEW YORK 09/30/15 · Livecube transforms how people connect and share ideas...

Wiknix: tech magazine provides latest gadgets news

New York, NY 09/26/15 · It can be hard to know who to...

New Farm-to-Table Chef Joins Canada's Favourite Spa

GRAFTON, ON 09/25/15 · Ste. Anne's Spa ( has just hired Jeffrey...

Moment Soundbar brings family together with Karaoke home entertainment

Los Angeles, Ca 09/17/15 · With the rising cost of family outings, more...


Los Angeles, Ca 09/16/15 · Moment is the world’s first compact soundbar that...

Moment, the minimalist soundbar to replace all soundbars

Los Angeles, CA 09/15/15 · Moment™: A case of less is more. Moment,...